Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
DiaMedica Therapeutics Inc
DMACCurrent price
4.12 USD
-0.17 USD (-3.96%)
Last closed
4.26 USD
Company
www.diamedica.com
ISIN
CA25253X2077
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
183 815 552 USD
Yield for 12 month
+68.16 %
1Y
3Y
5Y
10Y
15Y
DMAC
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from serious diseases with a focus on acute ischemic stroke. Its lead candidate is DM199, a pharmaceutically active recombinant form of the human tissue kallikrein-1 protein, which is in Phase II/III trials for the treatment of acute ischemic stroke, as well as that is in Phase 2 to treat cardio-renal disease. The company also develops DM300, which is in preclinical stage for the treatment of severe inflammatory diseases. In addition, it develops treatment for neurological disease. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota. Address: 301 Carlson Parkway, Minneapolis, MN, United States, 55305
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
7 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-30 000 USD
Last Year
-25 000 USD
Current Quarter
-10 000 USD
Last Quarter
-8 000 USD
Key Figures DMAC
1 year
3 years
5 years
10 years
EBITDA
-22 350 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-23.54 %
PEG Ratio
–
Return On Equity TTM
-35.18 %
Wall Street Target Price
7 USD
Revenue TTM
–
Book Value
1.25 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.51 USD
Diluted Eps TTM
-0.51 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics DMAC
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History DMAC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:20
Payout Ratio
–
Last Split Date
15.11.2018
Dividend Date
15.11.2018
Stock Valuation DMAC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-0.9637
Price Book MRQ
3.4413
Financials DMAC
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators DMAC
For 52 weeks
2.12 USD
4.95 USD
50 Day MA
4.27 USD
Shares Short Prior Month
152 275
200 Day MA
3.32 USD
Short Ratio
3
Shares Short
183 291
Short Percent
0.62 %
BeatStart